Jason Karamchandani

Summary

Publications

  1. doi request reprint Highly proliferative sellar chordoma with unusually rapid recurrence
    Jason Karamchandani
    Department of Pathology and Laboratory Medicine, St Michael s Hospital, University of Toronto, Toronto, ON, Canada
    Neuropathology 33:424-30. 2013
  2. doi request reprint Sox10 and S100 in the diagnosis of soft-tissue neoplasms
    Jason R Karamchandani
    Department of Pathology, Stanford University Medical Center, Palo Alto, CA 94025, USA
    Appl Immunohistochem Mol Morphol 20:445-50. 2012
  3. doi request reprint Extravascular papillary endothelial hyperplasia mimicking neoplasm after radiosurgery: case report
    Jason Karamchandani
    Department of Pathology, Stanford University Medical Center, Palo Alto, California, USA
    Neurosurgery 70:E1043-8; discussion E1048. 2012
  4. ncbi request reprint Preclinical efficacy of the anti-hepatocyte growth factor antibody ficlatuzumab in a mouse brain orthotopic glioma model evaluated by bioluminescence, PET, and MRI
    Erik S Mittra
    Authors Affiliations Molecular Imaging Program, Department of Radiology, System Medicine, Department of Pediatrics, Division of Neuropathology, Department of Pathology, Merck Research Laboratories, Palo Alto, California AVEO Pharmaceuticals Inc, Cambridge, Massachusettes and Bio X Program, Department of Bioengineering, Department of Materials Science and Engineering, Stanford University, Stanford
    Clin Cancer Res 19:5711-21. 2013
  5. ncbi request reprint Mouse models of glioblastoma: lessons learned and questions to be answered
    Loury Janbazian
    Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for SickKids, University of Toronto, 30 Bond St, Toronto, ON, M5B 1W8, Canada
    J Neurooncol 118:1-8. 2014
  6. doi request reprint Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases
    Ankur R Sangoi
    Department of Pathology, Stanford University, Stanford, CA, USA
    Mod Pathol 24:425-9. 2011

Detail Information

Publications6

  1. doi request reprint Highly proliferative sellar chordoma with unusually rapid recurrence
    Jason Karamchandani
    Department of Pathology and Laboratory Medicine, St Michael s Hospital, University of Toronto, Toronto, ON, Canada
    Neuropathology 33:424-30. 2013
    ..The evaluation of the additional biomarkers, including makers of EMT studied in this, case may allow for identification of aggressive chordomas in which the tempo of disease is significantly more rapid than in typical cases of chordoma. ..
  2. doi request reprint Sox10 and S100 in the diagnosis of soft-tissue neoplasms
    Jason R Karamchandani
    Department of Pathology, Stanford University Medical Center, Palo Alto, CA 94025, USA
    Appl Immunohistochem Mol Morphol 20:445-50. 2012
    ..Sox10 should be used in the place of or along with S100 in soft tissue tumor diagnosis...
  3. doi request reprint Extravascular papillary endothelial hyperplasia mimicking neoplasm after radiosurgery: case report
    Jason Karamchandani
    Department of Pathology, Stanford University Medical Center, Palo Alto, California, USA
    Neurosurgery 70:E1043-8; discussion E1048. 2012
    ..We report the largest series of patients with histologically confirmed intracranial extravascular PEH developing in the field of previous treatment with stereotactic radiosurgery...
  4. ncbi request reprint Preclinical efficacy of the anti-hepatocyte growth factor antibody ficlatuzumab in a mouse brain orthotopic glioma model evaluated by bioluminescence, PET, and MRI
    Erik S Mittra
    Authors Affiliations Molecular Imaging Program, Department of Radiology, System Medicine, Department of Pediatrics, Division of Neuropathology, Department of Pathology, Merck Research Laboratories, Palo Alto, California AVEO Pharmaceuticals Inc, Cambridge, Massachusettes and Bio X Program, Department of Bioengineering, Department of Materials Science and Engineering, Stanford University, Stanford
    Clin Cancer Res 19:5711-21. 2013
    ..Ficlatuzumab is a novel therapeutic agent targeting the hepatocyte growth factor (HGF)/c-MET pathway. We summarize extensive preclinical work using this agent in a mouse brain orthotopic model of glioblastoma...
  5. ncbi request reprint Mouse models of glioblastoma: lessons learned and questions to be answered
    Loury Janbazian
    Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for SickKids, University of Toronto, 30 Bond St, Toronto, ON, M5B 1W8, Canada
    J Neurooncol 118:1-8. 2014
    ..In this review, we will summarize the current state of mouse modeling in glioma, with a focus on how these models may inform our understanding of this disease and its treatment. ..
  6. doi request reprint Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases
    Ankur R Sangoi
    Department of Pathology, Stanford University, Stanford, CA, USA
    Mod Pathol 24:425-9. 2011
    ..This study confirms the specificity of brachyury for chordoma in the differential diagnostic distinction from the potential genitourinary mimics, germ cell tumors and metastatic clear cell renal cell carcinoma...